Rhabdomyosarcoma (RMS) is a pediatric soft tissue cancer with poor prognosis in cases of metastasis. Different signal transduction pathways have been studied in RMS cells as to shed some light into the tumorigenesis and metastasis mechanisms of this cancer in the search for new diagnostic and therapeutic strategies. The Notch pathway, which regulates cell survival, is widely studied in different cancers, including sarcomas and its activation has been known to induce cell motility. To this end, the present review explores the role of the Notch signaling pathway in the progression of RMS and in potential therapeutic strategies.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.